Vaccinia Virus Inhibits T Cell Receptor–Dependent Responses by Human γδ T Cells

• Published in: The Journal of infectious diseases 2007-01, Vol.195 (1), p.37-45
• Main Authors: Li, Haishan, Deetz, Carl O., Zapata, Juan Carlos, Cairo, Cristiana, Hebbeler, Andrew M., Propp, Nadia, Salvato, Maria S., Shao, Yiming, Pauza, C. David
• Format: Article
• Language: English
• Subjects: Antibodies; B lymphocytes; Biological and medical sciences; Cultured cells; Cytotoxicity; Fundamental and applied biological sciences. Psychology; HeLa cells; Infections; Infectious diseases; Medical sciences; Microbiology; Miscellaneous; T cell antigen receptors; T lymphocytes; Vaccinia virus; Virology; Viruses
• ISSN: 0022-1899; 1537-6613
• DOI: 10.1086/509823

Vaccinia virus (VV) is an effective vaccine and vector but has evolved multiple mechanisms for evading host immunity. We characterized the interactions of VV (TianTan and New York City Board of Health strains) with human γδ T cells because of the role they play in immune control of this virus. Exposure to VV failed to trigger proliferative responses in γδ T cells from unprimed individuals, but it was an unexpected finding that VV blocked responses to model antigens by the Vγ2Vδ2 T cell subset. Infectious or ultraviolet light–inactivated VV inhibited proliferative Vγ2Vδ2 T cell responses to phosphoantigens and tumor cells, prevented cytolysis of Daudi B cells, and reduced cytokine production. Inhibiting Vγ2Vδ2 T cells may be a mechanism for evading host immunity and increasing VV virulence. Increased VV replication or expression in the absence of γδ T cell responses might contribute to its potency as a vaccine against poxvirus and recombinant antigens